Results 91 to 100 of about 8,472 (213)

Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt

, 1998
Azathioprine-induced veno-occlusive disease of the liver mainly described after kidney transplantation is as rare as severe with a high mortality due to acute portal hypertension and liver failure.
Lemoine, A, Samuel, D, Azoulay, D, Bismuth, H, Charpentier, B, Castaing, D, Majno, Pietro, Reynes, M   +7 more
core  

Transjugular Intrahepatic Portosystemic Shunt Reduction for Medically Refractory Hepatic Encephalopathy

Purpose Transjugular intrahepatic portosystemic shunt (TIPS) is an established intervention for symptomatic portal hypertension, with many patients experiencing hepatic encephalopathy (HE) as an undesirable side effect.
Brandon Toliver, Adam Schmitz, Matthew Thornburg, Paul Haste   +3 more
core   +1 more source

Direct Intrahepatic Portosystemic Shunt in Budd-Chiari Syndrome: A Case Report and Review of the Literature

Case Reports in Radiology, 2018
Transjugular intrahepatic portosystemic shunt (TIPS) is an alternative interventional procedure used to manage refractory Budd-Chiari syndrome (BCS) when conservative medical therapy has failed.
V. Chandra, E. Wajswol, M. Shahid, A. Kumar, S. Contractor   +4 more
doaj   +1 more source

Correction to “The Dynamic Evolution of Lipid Profiles Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis”

Portal Hypertension &Cirrhosis, EarlyView.
wiley   +1 more source

Balloon-Assisted Reduction of Transjugular Intrahepatic Portosystemic Shunt (BART) Using Polytetrafluoroethylene Stent-Grafts

, 2016
Balloon-Assisted Reduction of Transjugular Intrahepatic Portosystemic Shunt (BART) Using Polytetrafluoroethylene Stent ...
HK Kok (14446083), MF Given (15767408), MJ Lee (14480232), FP McGrath (15767411), Hamed Asadi (13059153), E Ryan (9891101)   +5 more
core  

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension-Induced Refractory Ascites Due to Metastatic Carcinomatous Liver Disease

, 2018
Three patients with a medical history of breast carcinoma and metastatic carcinomatous liver disease associated with severe portal hypertension and refractory ascites are presented. Transjugular intrahepatic portosystemic shunt creation was considered as
Vanslembrouck, Ragna, Geeroms, Barbara, Maleux, Geert, De Hertogh, Gert, Wildiers, Hans, Nevens, Frederik   +5 more
core   +1 more source

Correction to “Chinese Registry on Transjugular Intrahepatic Portosystemic Shunts (CN‐TIPS): Protocol for a Registry‐Based, Prospective Prognostic Study”

Portal Hypertension &Cirrhosis, EarlyView.
wiley   +1 more source

Life-Threatening Bleeding from Peristomal Varices after Cystoprostatectomy: Multimodal Approach in a Cirrhotic, Encephalopathic Patient with Severe Portal Hypertension

Case Reports in Urology, 2015
The bleeding of peristomal varices due to a portosystemic shunt is rare but potentially life-threatening in cirrhotic patients with portal hypertension.
Sergej E. L. Staubli, Tobias Gramann, Christoph Schwab, David Semela, Lukas Hechelhammer, Daniel S. Engeler, Hans-Peter Schmid, Dominik Abt, Livio Mordasini   +8 more
doaj   +1 more source

ransjugular intrahepatic portosystemic shunt: a case report of rescue management of unrestrainable variceal bleeding in a pregnant woman

, 2008
Liver cirrhosis complications in pregnant women are frequent and death rate secondary to variceal bleeding is relevant. Both sclerotherapy and banding ligation seem to be safe procedures in pregnancy; when bleeding is not arrested endoscopically an ...
Cappelli A, Compagnone G, Azzaroli F, Cecinato P., Cappelli A., Golfieri R, Montagnani M., Lodato F., Compagnone G., Montagnani M, Festi D, Festi D., Colecchia A, Cecinato P, Azzaroli F., Mazzella G, Golfieri R., Colecchia A., Mazzella G., Lodato F   +19 more
core   +1 more source

Transjugular intrahepatic portosystemic shunt indications, contraindications.

The formation of transjugular intrahepatic portosystemic shunt is effective in managing severe complications of cirrhotic portal hypertension. Due to its impact on hemodynamics, careful consideration of contraindications is essential.
Lampickaitė, Gabija,
core